Skip to Content
Coronavirus

FDA needs time to review suitable vaccine for teens, Moderna says

By , ,
Published 4:41 PM

Heart inflammation risk possibly to go under review

U.S. (KYMA, KECY/CNN) - On Sunday, October 31, Moderna made a statement regarding the Food and Drug Administration wanting to vaccinate 12 - 17-year-olds.

There may be a risk posed in teens if they get vaccinated, with the FDA needing time to review heart inflammation effects that could possibly occur.

If a review does go underway then the vaccine will be delayed until January.

Myocarditis is a rare type of heart inflammation that has been linked to both Pfizer's and Modern's vaccines, although it can be resolved through medicine.

Article Topic Follows: Coronavirus

Jump to comments ↓

Author Profile Photo

Marcos Icahuate

Reach out to Marcos with your story ideas at marcos.icahuate@kecytv.com.

Author Profile Photo

Arlette Yousif

Arlette Yousif joined KYMA in November 2020 as a Multi Media Journalist. She holds a BA in Journalism with a minor in Film.

You can reach out to Arlette for at arlette.yousif@kecytv.com.

CNN Newsource

BE PART OF THE CONVERSATION

KYMA KECY is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content